David Tepper Stryker Corp Transaction History

Appaloosa LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$145.0 - $178.65 $13.3 Million - $16.4 Million	-92,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$163.25 - $177.68 $36.6 Million - $39.8 Million	-224,000 Reduced 70.89%	92,000 $16.3 Million
Q2 2018 Aug 14, 2018	SELL	$155.17 - $179.78 $8.53 Million - $9.89 Million	-55,000 Reduced 14.82%	316,000 $53.4 Million
Q4 2017 Feb 14, 2018	SELL	$143.51 - $159.74 $23.2 Million - $25.9 Million	-162,000 Reduced 30.39%	371,000 $57.4 Million
Q3 2017 Nov 14, 2017	BUY	$138.36 - $147.87 $73.7 Million - $78.8 Million	533,000	533,000 $75.7 Million

2,232

284M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $138B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Appaloosa LP, based on Form 13F filings with the SEC.

Stay updated on Appaloosa LP and David Tepper with notifications on news.